Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

In vitro meat production system: why and how?

Sharma S, Thind SS, Kaur A.

J Food Sci Technol. 2015 Dec;52(12):7599-607. doi: 10.1007/s13197-015-1972-3. Epub 2015 Jul 31. Review.

2.

Sporadic Creutzfeldt-Jakob Disease: Prion Pathology in Medulla Oblongata-Possible Routes of Infection and Host Susceptibility.

Iacono D, Ferrari S, Gelati M, Zanusso G, Mariotto S, Monaco S.

Biomed Res Int. 2015;2015:396791. doi: 10.1155/2015/396791. Epub 2015 Sep 17.

3.

A study of clinical profile, radiological and electroencephalographic characteristics of suspected Creutzfeldt-Jakob disease in a tertiary care centre in South India.

Mahale RR, Javali M, Mehta A, Sharma S, Acharya P, Srinivasa R.

J Neurosci Rural Pract. 2015 Jan;6(1):39-50. doi: 10.4103/0976-3147.143189.

4.

Creutzfeldt-Jakob disease: typical imaging findings.

Felix-Morais R, Andrade LC, Rebelo O.

BMJ Case Rep. 2014 Mar 28;2014. pii: bcr2014203997. doi: 10.1136/bcr-2014-203997. No abstract available.

5.

Case series of probable sporadic Creutzfeldt-Jakob disease from Eastern India.

Biswas A, Khandelwal N, Pandit A, Roy A, Guin DS, Gangopadhyay G, Senapati A.

Ann Indian Acad Neurol. 2013 Oct;16(4):659-63. doi: 10.4103/0972-2327.120486.

6.

Small-molecule theranostic probes: a promising future in neurodegenerative diseases.

Aulić S, Bolognesi ML, Legname G.

Int J Cell Biol. 2013;2013:150952. doi: 10.1155/2013/150952. Epub 2013 Nov 12. Review.

7.

Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy.

Kovaleva J, Peters FT, van der Mei HC, Degener JE.

Clin Microbiol Rev. 2013 Apr;26(2):231-54. doi: 10.1128/CMR.00085-12. Review.

8.

Diffusion-weighted imaging: As the first diagnostic clue to Creutzfeldt Jacob disease.

Kumaran SP, Gupta K, Pushpa B, Viswamitra S, Joshy E.

J Neurosci Rural Pract. 2012 Sep;3(3):408-10. doi: 10.4103/0976-3147.102645.

9.

Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.

Yuen KC, Amin R.

Patient Prefer Adherence. 2011 Mar 10;5:117-24. doi: 10.2147/PPA.S10985.

10.

Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance.

Maccarrone M, Bernardi G, Agrò AF, Centonze D.

Br J Pharmacol. 2011 Aug;163(7):1379-90. doi: 10.1111/j.1476-5381.2011.01277.x. Review.

11.

Rapidly progressive dementias and the treatment of human prion diseases.

Appleby BS, Lyketsos CG.

Expert Opin Pharmacother. 2011 Jan;12(1):1-12. doi: 10.1517/14656566.2010.514903. Epub 2010 Nov 23. Review.

12.

Clinical experience with Flebogamma 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease.

Ballow M.

Clin Exp Immunol. 2009 Sep;157 Suppl 1:22-5. doi: 10.1111/j.1365-2249.2009.03951.x. Erratum in: Clin Exp Immunol. 2009 Sep;157(3):446.

13.

Creutzfeldt-Jakob disease: case discussion and imaging review.

Morgan C, Gupta M, El-Feky W, Shamim S, Opatowsky M.

Proc (Bayl Univ Med Cent). 2009 Jan;22(1):69-71. No abstract available.

14.

Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood.

Freudenberg JA, Bembas K, Greene MI, Zhang H.

Methods. 2008 Sep;46(1):33-8. doi: 10.1016/j.ymeth.2008.05.005. Epub 2008 Jun 23. Review.

15.

Creutzfeldt-Jakob disease and infection control.

Johnston L, Conly J.

Can J Infect Dis. 2001 Nov;12(6):332-6. No abstract available.

16.

Contact-induced structure transformation in transmembrane prion propagation.

Ou DM, Chen CC, Chen CM.

Biophys J. 2007 Apr 15;92(8):2704-10. Epub 2007 Jan 26.

17.

Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals.

Chang B, Cheng X, Yin S, Pan T, Zhang H, Wong P, Kang SC, Xiao F, Yan H, Li C, Wolfe LL, Miller MW, Wisniewski T, Greene MI, Sy MS.

Clin Vaccine Immunol. 2007 Jan;14(1):36-43. Epub 2006 Nov 1.

18.

Understanding and meeting the needs of those using growth hormone injection devices.

Dumas H, Panayiotopoulos P, Parker D, Pongpairochana V.

BMC Endocr Disord. 2006 Oct 11;6:5.

19.

Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion.

Ayache S, Panelli MC, Byrne KM, Slezak S, Leitman SF, Marincola FM, Stroncek DF.

J Transl Med. 2006 Oct 4;4:40.

20.

The intriguing prion disorders.

Abid K, Soto C.

Cell Mol Life Sci. 2006 Oct;63(19-20):2342-51. Review.

Supplemental Content

Support Center